山東未名生物醫藥(yao)(yao)股份有限公(gong)司(si)（以(yi)下簡稱(cheng)“未名醫藥(yao)(yao)”或“公(gong)司(si)”）是(shi)未名集團(tuan)控股的在(zai)深圳證(zheng)券交易所上市的A股公(gong)眾公(gong)司(si)，證(zheng)券簡稱(cheng)：未名醫藥(yao)(yao)，證(zheng)券代碼：002581。公(gong)司(si)于2015年(nian)10月19日經(jing)重大資產(chan)重組(zu)原“淄博萬昌科(ke)技(ji)股(gu)份有(you)(you)限(xian)公(gong)(gong)司(si)”更(geng)名而成。公(gong)(gong)司(si)擁(yong)有(you)(you)未(wei)名生(sheng)(sheng)(sheng)物醫藥(yao)有(you)(you)限(xian)公(gong)(gong)司(si)（廈門）、天津(jin)未(wei)名生(sheng)(sheng)(sheng)物醫藥(yao)有(you)(you)限(xian)公(gong)(gong)司(si)、北京科(ke)興生(sheng)(sheng)(sheng)物制品(pin)有(you)(you)限(xian)公(gong)(gong)司(si)、山(shan)東(dong)未(wei)名天源生(sheng)(sheng)(sheng)物科(ke)技(ji)有(you)(you)限(xian)公(gong)(gong)司(si)、北京未(wei)名西大生(sheng)(sheng)(sheng)物科(ke)技(ji)有(you)(you)限(xian)公(gong)(gong)司(si)、合肥北大未(wei)名生(sheng)(sheng)(sheng)物制藥(yao)有(you)(you)限(xian)公(gong)(gong)司(si)等(deng)下(xia)屬企(qi)業(ye)或生(sheng)(sheng)(sheng)產基地。
未(wei)(wei)名集(ji)團(tuan)三大夢想之一是“解決中(zhong)國健(jian)康(kang)問(wen)題(ti)”：通過(guo)發展生(sheng)物醫(yi)藥(yao)(yao)產(chan)業，建(jian)立(li)(li)健(jian)康(kang)產(chan)品(pin)(pin)供給(gei)體(ti)系(xi)；通過(guo)發展現(xian)代中(zhong)醫(yi)藥(yao)(yao)，建(jian)立(li)(li)中(zhong)國特色的健(jian)康(kang)服務體(ti)系(xi)；通過(guo)實施GHP計劃，建(jian)立(li)(li)生(sheng)命健(jian)康(kang)管理(li)體(ti)系(xi)。未(wei)(wei)名醫(yi)藥(yao)(yao)將發展藥(yao)(yao)物制造、新(xin)藥(yao)(yao)研發、產(chan)品(pin)(pin)配(pei)送三大系(xi)統，建(jian)成(cheng)完善的健(jian)康(kang)產(chan)品(pin)(pin)供給(gei)體(ti)系(xi)，通過(guo)實施“百千萬(wan)億工程”，到2030年實現(xian)以下目標：未(wei)(wei)名醫(yi)藥(yao)(yao)占中(zhong)國醫(yi)藥(yao)(yao)市場總(zong)銷售額的10%、占生(sheng)物醫(yi)藥(yao)(yao)市場總(zong)銷售的50%、上市公司（002581）市值超過(guo)一萬(wan)億；通過(guo)建(jian)立(li)(li)新(xin)藥(yao)(yao)高速公路，未(wei)(wei)名醫(yi)藥(yao)(yao)將每年獲得25張新(xin)藥(yao)(yao)證書(shu)；通過(guo)國際化的企(qi)業重組并購，未(wei)(wei)名醫(yi)藥(yao)(yao)成(cheng)為世界上較大的醫(yi)藥(yao)(yao)企(qi)業集(ji)團(tuan)。
買購網APP
手機版Maigoo
藥品
